Bioton SA (WAR:BIO)

TOP CONTRIBUTORS

Marcin Nowak

BIOTON S.A. sells finished goods, commodities and services through BIOTON TRADE Sp. o.o., a pharmaceutical wholesale company incorporated in 1998. Subsequent distribution takes place through other pharmaceutical wholesalers and pharmacies.

Distribution in Poland The Company’s internal and external sales forces are responsible for marketing and distribution within Poland. BIOTON S.A.'s sales and marketing departments primarily aim to boost sales and ensure efficient and effective distribution so that BIOTON products are readily available everywhere in Poland. BIOTON has long enjoyed a leading position in most segments of the pharmaceutical market in which it operates thanks to the efficient organisation of its sales force.

Foreign distribution In line with its global expansion strategy, BIOTON S.A. registers its products in various countries around the world. Products are sold on foreign markets under co-operation agreements and sales agreements concluded with foreign and domestic partners. Members of the BIOTON Group pursue innovative projects whose performance and commercialisation supports common development.

BIOTON aims to reinforce its position of a biotechnological company with a global reach. The Company is able to pursue its strategic objectives of protecting Patients’ health and improving the quality of their lives by participating in research and development projects, promoting the expansion of its product portfolio and making well-informed business decisions. BIOTON fulfils its stated mission by implementing strategies and development plans aimed at:

   * reinforcing BIOTON's status on the Polish insulin market
   * promoting BIOTON's insulin world-wide by maximising its share of the existing markets and entering new ones
   * developing innovative, clinically important medicinal products, including biotechnological drugs developed by members of the BIOTON Group
   * expanding BIOTON’s generic drug portfolio.

[1]